Nov 25, 2020
AstraZeneca and Oxford reported on 22 November in separate press releases that an interim analysis of trials in the United Kingdom and Brazil found an “average efficacy” of 70%. Both studies gave volunteers a “prime” first dose and a booster shot at least 1 month...
Nov 16, 2020
“We determined that disrupting the SKI complex keeps the virus from copying itself, which essentially destroys it,” said study corresponding author Matthew Frieman, Ph.D., Associate Professor of Microbiology and Immunology at the UMSOM. “We also...
Nov 6, 2020
Researchers discover microbes regulate the development of specialized immune cells in the thymus that play a critical role in mucosal tolerance. Quelle: Novel communication between intestinal microbes and developing immune cells in the thymus: Regulation of thymic...
Oct 9, 2020
CRISPR-based approach is much faster than current diagnostics, but does have some limitations Quelle: New test detects coronavirus in just 5 minutes
Oct 2, 2020
A fast-tracked manufacturing and marketing approval for Favipiravir was granted to Glenmark Pharmaceuticals by the Drug Controller General of India (DCGI) for restricted emergency use in mild to moderate cases of COVID-19. With this approval,...
Oct 2, 2020
Impact of the gut microbiota on atorvastatin mediated effects on blood lipidsThe composition of our individual gut microbiota contributes to the digestion and absorption of nutrients from food. Similarly, orally administered medications experience the same digestive...
Translate »
